Form4insider filings, from the source

SEC Form 4 · accession 0001209191-18-042143

ARENA PHARMACEUTICALS INC · ARNA

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Period of report
Jul 6, 2018
Accepted (ET)
Jul 10, 2018 · 4:14 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001080709

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF1Jul 6, 2018A1,674$0.00A1,674D
Common StockF2Jul 6, 2018A3,070$0.00A4,744D

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Stock Option (right to buy)F3$44.79Jul 6, 2018A2,500A—Jul 6, 2025Common Stock2,5002,500D
Stock Option (right to buy)F4$44.79Jul 6, 2018A4,583A—Jul 6, 2025Common Stock4,5834,583D

Explanation of responses